Company / SG&A Expense
Omega Healthcare Investors SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$104.1M
FY2025
5-year range
$57.9M / $104.1M
FY2021-FY2025
Trend
+18.3%
vs FY2024
Sector context
#36 of 131
Real Estate
What the data says
At $104M, Omega Healthcare Investors's sg&a expense ranks #96 of 131 in the Real Estate sector. SG&A Expense has increased for 4 consecutive years, from $58M in FY2021 to $104M in FY2025.
Based on SEC 10-K filings.
$104M in FY2025 with a 5-year CAGR of +10.4%.
Increased from $65M to $104M over the past 2 years.
Real Estate sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +20.3%
- 5-Year CAGR
- +10.4%
- 10-Year CAGR
- -
Sector benchmark
#96 of 131 in Real EstateTop 73% of 131This company $104.1M Sector average $159.5M
▼
-34.7% below sector average
Key checks
Key Insights
- Omega Healthcare Investors's sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +10.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 18.3% year-over-year.
- Ranks #36 out of 131 companies in the Real Estate sector.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- Strong profit margin: 21.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $104.1M | +18.3% |
| FY2024 | $88.0M | +36.2% |
| FY2023 | $64.6M | +7.9% |
| FY2022 | $59.9M | +3.5% |
| FY2021 | $57.9M | -8.9% |
| FY2020 | $63.5M | +9.7% |
| FY2019 | $57.9M | -8.9% |
| FY2018 | $63.5M | +33.2% |
| FY2017 | $47.7M | +4.0% |
| FY2016 | $45.9M | +18.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026